Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01541358 · ClinicalTrials.gov registry record · NA
Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01541358: Clinical Trial NA study, sponsored by Stanford University.
NCT01541358 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01541358, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This clinical trial studies fluorine F-18 sodium fluoride positron emission tomography (PET)/computed tomography (CT) in diagnosing bone tumors in patients with cancer. Diagnostic procedures, such as fluorine F-18 sodium fluoride PET/CT, may help find and diagnose bone cancer
Primary Outcome
F-18 NaF is a positron emission tomography (PET) bone imaging agent that targets changes in the bone. The fluoride ions are taken up in areas of the bone that have increased bone remodeling (bone repair) and increased blood flow, which is indicative of diseases such as cancer.
Interventions
- PROCEDURE positron emission tomography/computed tomography
- RADIATION fluorine F 18 sodium fluoride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-05 |
| Est. Completion | 2012-09 |
| Phase | NA |
Why NCT01541358 stopped before completion
NCT01541358 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which positron emission tomography/computed tomography is the first listed.
NCT01541358 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01541358 about?
NCT01541358 is a clinical study titled "Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer". This clinical trial studies fluorine F-18 sodium fluoride positron emission tomography (PET)/computed tomography (CT) in diagnosing bone tumors in patients with cancer. Diagnostic procedures, such as fluorine F-18 sodium fluoride PET/CT, may help find and diagnose bone cancer
What is the current status of trial NCT01541358?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2012-05. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01541358?
The interventions under investigation include: positron emission tomography/computed tomography (PROCEDURE), fluorine F 18 sodium fluoride (RADIATION).
Who is sponsoring clinical trial NCT01541358?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01541358's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia